Hopefully a new treatment for spasticity and pain in MS

Fast Forward and Concert Pharmaceuticals Announce Collaboration to Advance Novel Treatment for Spasticity and Pain in Multiple Sclerosis. Press release March 5, 2012

"Fast Forward, LLC, the National MS Society's subsidiary devoted to bridging the gap between research and drug development, and Concert Pharmaceuticals, Inc. (Lexington, MA) today announced a new collaboration to fund the preclinical advancement of C-21191, a substance that has been modulated to help improve an experimental therapy with the potential for treating spasticity and pain in MS. These are two common and often debilitating symptoms experienced by people with MS. Fast Forward is committing up to $750,000 to help advance development of C-21191 toward clinical trials in people with MS. ....." 


"This is brilliant news. I have been lobbying Pharma for years to take MS-spasticty seriously. I must spend a good 10-15% of my clinical activities managing spasticity and dealing with the side effects of the current agents that are appalling. I am sure that any new anti-spastic drug with a better side effect profile and similar efficacy to current runners will be a block-buster drug. If you have advanced MS and suffer from spasticity you should be cheering and celebrating this news."


"Thank you FastForward, you are doing a great job!"

Labels: , ,